| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $184.5M | -1.9% |
| Cost of Revenue | $9.0M | -28.0% |
| R&D Expense | $36.4M | +1.2% |
| SG&A Expense | $70.6M | -5.0% |
| Operating Income | $14.7M | +179.9% |
| Pre-tax Income | $12.2M | +178.2% |
| Income Tax | $46K | -50.5% |
| Net Income | $7.6M | +177.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $10.1M | -9.8% |
| Current Assets | $69.5M | +35.0% |
| Total Assets | $181.9M | +8.9% |
| Current Liabilities | $30.4M | -9.7% |
| Total Liabilities | $61.8M | -3.2% |
| Stockholders' Equity | $36.1M | +120.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $36.7M | +60.0% |
| Investing Cash Flow | -$11.6M | +2.0% |
| Financing Cash Flow | -$7.4M | -40.3% |